STAT3 and cancer: The activation of STAT3 and NF-κB signaling pathways by pro-inflammatory cytokines triggers the expression of the c-myc oncogene and MMP13, which subsequently contributes to EMT, persistent inflammation, and, ultimately, cancer development.